Viking Therapeutics, Inc.
VKTX
$33.43
$0.230.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.28% | -11.54% | 149.29% | 147.30% | 139.81% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,939.86% | 34.53% | -55.27% | 158.66% | -85.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 395.88% | 389.69% | 32.47% | 1.98% | -39.48% |
| Total Current Assets | -12.55% | -10.38% | 147.05% | 145.65% | 136.80% |
|
|
|||||
| Total Current Assets | -12.55% | -10.38% | 147.05% | 145.65% | 136.80% |
| Net Property, Plant & Equipment | -20.16% | -15.21% | -10.92% | -7.25% | -23.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -60.87% | -40.46% | -26.62% | -22.70% | 181.63% |
| Total Assets | -12.57% | -10.39% | 146.50% | 145.10% | 136.30% |
|
|
|||||
| Total Accounts Payable | -50.46% | 47.41% | 30.63% | -95.55% | 97.65% |
| Total Accrued Expenses | 90.34% | -58.22% | 51.44% | 238.32% | 80.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.12% | 51.37% | 50.93% | 50.47% | 6.37% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.45% | -40.28% | 43.26% | 91.61% | 86.18% |
|
|
|||||
| Total Current Liabilities | 27.45% | -40.28% | 43.26% | 91.61% | 86.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -46.48% | -41.08% | -32.69% | -25.83% | -30.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.26% | -40.30% | 39.72% | 83.32% | 77.38% |
|
|
|||||
| Common Stock & APIC | 3.25% | 2.97% | 86.62% | 86.80% | 86.38% |
| Retained Earnings | -40.12% | -31.64% | -29.10% | -28.06% | -29.25% |
| Treasury Stock & Other | 92.69% | 86.49% | 89.03% | 121.19% | 71.00% |
| Total Common Equity | -13.63% | -9.31% | 152.65% | 147.51% | 138.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.63% | -9.31% | 152.65% | 147.51% | 138.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.63% | -9.31% | 152.65% | 147.51% | 138.52% |
|
|
|||||